Insider Trading History of Clemow Alastair J T

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Clemow Alastair J T since 2006. The trader's CIK number is 1247795. At the time of the last reporting, Clemow Alastair J T was the Director of Aevi Genomic Medicine, Llc. (stock ticker symbol CERC). Also see all insider trading activities at Aevi Genomic Medicine, Llc.

Note that in the past CLEMOW ALASTAIR J T also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Aevi Genomic Medicine, Llc (GNMX) by Clemow Alastair J T

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2017 GNMX 19,841 $24,999 0 $0 0 $0
2014 GNMX 12,195 $49,999 0 $0 0 $0
2013 GNMX 4,500 $26,005 0 $0 0 $0

Yearly summary of insider trading at Encore Medical Corp (ENMC) by Clemow Alastair J T

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 ENMC 0 $0 45,000 $294,750 45,000 $205,650


Insider trading activities at 2 companies by Clemow Alastair J T:

1. Aevi Genomic Medicine, Llc (GNMX)

2. Encore Medical Corp (ENMC)

Table 1. Insider trading of Aevi Genomic Medicine, Llc (GNMX) by Clemow Alastair J T

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2017-10-17 GNMX Buy 19,841 1.26 24,999
2014-12-01 MDGN Buy 12,195 4.10 49,999
2013-12-16 MDGN Buy 4,500 5.78 26,005

Table 2. Insider trading of Encore Medical Corp (ENMC) by Clemow Alastair J T

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-11-03 ENMC Sale 45,000 6.55 294,750
2006-11-03 ENMC Option Ex 45,000 4.57 205,650

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Clemow Alastair J T (Director of Aevi Genomic Medicine, Llc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.